SRCC Children’s Hospital, Mumbai – India
About Dr. Rashmi Dalvi
Dr. Rashmi Dalvi, a renowned Senior Consultant in Paediatrics at SRCC Children’s Hospital, Mumbai, brings over three decades of experience in pediatric hematology, pediatric oncology, and chronic childhood disorders. She is widely respected for her compassionate care and clinical precision in managing a wide spectrum of complex conditions, including anemias, bleeding and clotting disorders, bone marrow diseases, childhood cancers like leukemia and lymphomas, and immunological disorders.
With her deep expertise in pediatric cancer care and blood-related disorders, Dr. Dalvi plays a pivotal role in providing holistic, child-centered treatment. Her commitment to early diagnosis, use of precision medicine, and focus on long-term supportive care have made her a leading name in paediatric hematology and oncology in India.
Dr. Dalvi’s academic journey reflects her commitment to comprehensive pediatric training and excellence in clinical practice
- MBBS
- MD in Paediatrics
- Diploma in Child Health (DCH)
Memberships
- Mumbai Haematology Group
- Indian Society of Hematology And Transfusion Medicine
- International Society of Paediatric Oncology
- Indian Society of Medical And Pediatric Oncology
Major Conditions Treated
Dr. Rashmi Dalvi brings over three decades of expertise in diagnosing and managing a wide spectrum of complex childhood hematological and oncological disorders. Her clinical proficiency includes:- Paediatric Anemias ▸ Iron Deficiency Anemia, Thalassemia, Aplastic Anemia Specialized in genetic counseling, transfusion protocols, and long-term management
- Bleeding & Clotting Disorders ▸ Hemophilia, Idiopathic Thrombocytopenic Purpura (ITP) Expertise in factor replacement therapy, immunomodulation, and multidisciplinary care
- Bone Marrow Failure Syndromes ▸ Includes Fanconi Anemia, Diamond-Blackfan Anemia, and related inherited syndromes Advanced diagnostic and treatment planning using marrow biopsy and genetic tools
- Paediatric Cancers ▸ Leukemias (ALL, AML), Lymphomas (Hodgkin and Non-Hodgkin) Integrated approach involving chemotherapy, immunotherapy, and nutritional support
- Immunodeficiency Disorders Early identification and customized immunological care for Primary Immunodeficiencies
- Autoimmune & Histiocytic Disorders ▸ Hemophagocytic Lymphohistiocytosis (HLH), Juvenile Autoimmune Conditions Subspecialty experience in rare pediatric immune-mediated diseases Supportive Care in Paediatric Hemato-Oncology Emphasis on nutrition, pain management, psychosocial counseling, and infection control
- Early Diagnosis of Pediatric Malignancies Passionate about increasing awareness and reducing diagnostic delays in childhood cancers
- Precision Medicine in Childhood Blood Disorders Involved in implementing molecular diagnostics, targeted therapies, and personalized treatment plans
- Child-Centric Holistic Supportive Care Focus on compassionate care, family engagement, and improving quality of life during treatment
Current PositionSenior Consultant – Paediatrics
SRCC Children’s Hospital, MumbaiLeading clinical care in Pediatric Hematology, Oncology, and Chronic Disorders, with a patient-centric and evidence-based approach.Previous Roles
- Held consultant positions at several reputed pediatric hospitals and academic institutes across India
- Contributed extensively to clinical practice, medical education, and subspecialty development in Pediatric Hematology and Oncology
- Formerly associated with B.J. Wadia Hospital for Children, a premier pediatric institution in Mumbai
- Dr. L.M. Sanghvi Award – Best Oral Presentation, Bombay
- Best Subspecialty Chapter Award – Indian Academy of Pediatrics (IAP)
- SIOP Award for Best Paper – International Training Project, Portugal (Co-recipient)
- Felicitated at national forums for excellence in Paediatric Hematology
- Recognized for contributions to Paediatric Oncology education, research, and mentorship
- Delivered multiple keynote addresses at leading Paediatric Hematology-Oncology conferences
- Authored multiple papers in paediatric blood disorders and oncology
- Contributor to national paediatric treatment protocols and child health guidelines
- Researcher in immune and genetic conditions in children For example-
“Children aren’t just little adults—they deserve tailored, empathetic, and accurate care. That’s what I strive to provide each day.” – Dr. Rashmi Dalvi
- Successfully managed complex bone marrow failure in children with rare genetic syndromes
- Lifesaving treatment delivered to infants with immune deficiency through early diagnosis and specialized care
- Empowered families through education and long-term support in paediatric cancer cases
“Dr. Dalvi is not just a doctor—she is a guardian angel for our son. Her clear explanations and kind nature helped us through the toughest phase of our lives.”
– Mrs. R. Deshmukh, Mumbai“She saved my daughter’s life from a rare bleeding disorder. We owe everything to her precision and patience.”
– Mr. A. Mehta, Pune“Even after treatment, Dr. Rashmi keeps in touch with us and always checks on my child’s progress. She truly cares.”
– Mrs. Lata Jain, Surat“We were overwhelmed with medical terms, but Dr. Rashmi broke everything down simply. Her warmth brought us hope.”
– Mohammed Farhan, Malegaon
Dr. Dalvi is an active member and thought leader in several esteemed national and international medical organizations:
- Mumbai Haematology Group (MHG)
- Indian Society of Hematology and Transfusion Medicine (ISHTM)
- Indian Society of Medical and Pediatric Oncology (ISMPO)
- International Society of Paediatric Oncology (SIOP)
- Continental President, SIOP-Asia (2018–2021) – Global leadership in pediatric oncology
- Professor & Head, Pediatrics & Pediatric Hematology-Oncology, Bombay Hospital Institute of Medical Sciences
- Visiting Consultant,
- NH-SRCC Children’s Hospital, Mumbai
- Pediatric Hematology Oncology – BMT Department, LTMG Medical College Hospita
- Alumnus of Seth G.S. Medical College / KEM Hospital, Mumbai
- Specialized training in Pediatric Hematology-Oncology (PHO)
- India (1988)
- Children’s Hospitals of Michigan (1996)
- Philadelphia (UICC-ICRETT Fellowship, 2001)
- Among the pioneers in Pediatric Hematology-Oncology in India
- Over 30 years of clinical and academic experience in PHO & Pediatric Immunology
- Former Faculty at B.J. Wadia Hospital for Children
- Numerous research publications, national & international conference presentations
- Clinical focus:
- Lymphomas
- Histiocytic Disorders & HLH
- Pediatric Nutrition & Supportive Care
- Cancer Registries & Early Diagnosis
- Active member, SIOP & SIOP-PODC Committee since 1992
- 🇮🇳 Founder, SIOP-India Project: “NTP-PPO” (Early Diagnosis & Treatment Abandonment in Childhood Cancer)
- Held leadership roles in:
- National PHO Society, India (Chair, 2009–2012)
- SIOP-PODC Education & Training Committee (Chair, 2010–2013)
- SIOP Asia 2020–21 Conference, Mumbai (Chair, Local Organizing Committee)
- SIOP-PARC Steering Committee (Member)
- SIOP Membership Committee (Vice-Chair)
- Asian Pediatric Hematology Oncology Group (APHOG) – Founder Member & Executive Council Member
- ICON Ethics Committee and Stem Cell Committee, KEM Hospital
Dr. Rashmi Dalvi is a strong proponent of integrating cutting-edge medical technologies and innovative treatment approaches in pediatric care. Her work reflects a forward-thinking mindset that combines evidence-based practice with the latest advancements in the field.Pioneering Clinical Research
Note: The above costs are approximate and may vary depending on the hospital infrastructure, treatment regimen, patient response, and use of newer agents or international protocols. Detailed estimates are provided after initial evaluation and case review.International Patient Support
- Actively involved in clinical trials and research studies exploring novel therapies for:
- Pediatric Leukemia – including targeted therapies, molecular diagnostics, and minimal residual disease (MRD) monitoring
- Hemophilia – participating in trials on extended half-life factor concentrates, gene therapy, and non-factor therapies such as emicizumab
- Collaborates with national and international research groups to improve treatment outcomes and promote evidence-based pediatric hematology-oncology
- Strong advocate for comprehensive, multidisciplinary care models for children with:
- Chronic illnesses, such as thalassemia, immunodeficiency disorders, and pediatric cancers
- Involvement of hematologists, oncologists, nutritionists, psychologists, social workers, and rehabilitation specialists to ensure holistic care
- Focus on personalized treatment plans, family counseling, and long-term follow-up to enhance quality of life and treatment compliance
- Emphasizes the role of technology in early diagnosis, such as:
- Genetic screening, flow cytometry, next-generation sequencing (NGS), and telemedicine consultations
- Contributed to the development of national protocols and clinical guidelines for managing rare pediatric hematological conditions
Consultation & Treatment Costs
Consultation Fee- Initial Consultation Fee: Subject to variation based on clinical complexity, case history, and diagnostic needs.
- Follow-Up Consultations: May vary depending on frequency and additional assessments required.
- Teleconsultation options may also be available on request.
- Diagnosis and disease severity
- Type and duration of therapy required
- Hospital infrastructure and support services
- Need for specialized diagnostics or multidisciplinary care
- Multidisciplinary cancer rounds play a key role in ensuring each treatment plan is:
- Evidence-based, involving inputs from pediatric oncologists, hematologists, radiologists, pathologists, and supportive care teams
- Continuously reviewed to adapt therapy based on response, side effects, and emerging needs
- Holistic, addressing not only medical but also psychological, nutritional, and rehabilitative aspects
| Treatment Modality | Estimated Cost Range (INR) |
| Initial Consultation + Basic Investigations | ₹2,000 – ₹6,000 |
| Chemotherapy (Per Cycle) | ₹15,000 – ₹60,000 |
| Blood Transfusion (Per Session) | ₹4,000 – ₹10,000 |
| Bone Marrow Aspiration & Biopsy | ₹10,000 – ₹20,000 |
| Management of Hemophilia (Factor Replacement) | ₹8,000 – ₹30,000 (per session) |
| Immunodeficiency Workup & Therapy | ₹20,000 – ₹80,000 |
| Pediatric Leukemia Treatment (Full Course Estimate) | ₹2.5 Lakhs – ₹8 Lakhs |
| Pediatric Lymphoma Treatment (Full Course Estimate) | ₹2 Lakhs – ₹6 Lakhs |
| Supportive & Nutritional Care (Monthly Estimate) | ₹5,000 – ₹15,000 |
- Languages Spoken: English, Hindi, Marathi
- Virtual Consultations: Available for national and international patients
- Assistance Services: Travel, visa, and accommodation support available via Cancer Rounds Team
Frequently Asked Questions
– Dr. Dalvi specializes in paediatric blood disorders, cancers, immune conditions, and supportive care in paediatric haematology and oncology.
– She is a Senior Consultant at SRCC Children’s Hospital, Mumbai.
– Yes, she is well-known for managing complex and rare conditions like bone marrow failure, primary immunodeficiencies, and histiocytic disorders.
– Yes, online and video consultations are available for remote and international patients through the Cancer Rounds Team.
– She speaks English, Hindi, and Marathi.
– You can schedule a priority appointment via the Cancer Rounds Team for a hassle-free experience.
– Her unmatched clinical precision, empathetic care model, and 30+ years of experience make her a leading name in paediatric haematology in India.
Nanavati Super Specialty Hospital, Mumbai - India
